Quantum BioPharma Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Quantum BioPharma has a total shareholder equity of $10.2M and total debt of $615.6K, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are $15.2M and $5.0M respectively.
Anahtar bilgiler
6.0%
Borç/özkaynak oranı
US$615.56k
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$3.33m |
| Eşitlik | US$10.20m |
| Toplam yükümlülükler | US$5.04m |
| Toplam varlıklar | US$15.25m |
Son finansal sağlık güncellemeleri
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 0K91's short term assets ($10.0M) exceed its short term liabilities ($5.0M).
Uzun Vadeli Yükümlülükler: 0K91 has no long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 0K91 has more cash than its total debt.
Borcun Azaltılması: 0K91's debt to equity ratio has increased from 2.9% to 6% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: 0K91 has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Tahmini Nakit Akışı: 0K91 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.